Company Overview and News

 
Tesla: With Profitability On The Horizon, Now Is The Time To Go Long

2018-09-27 seekingalpha
Shares at current pricing levels support the narrative of a 2020 - 2021 valuation in the range of 30 times price to earnings.
VLKAF KDR SCTY KDRYY

3
Lithium Junior Miner News For The Month Of September 2018

2018-09-25 seekingalpha
Lithium spot prices in China fall slightly, and global contract prices rise - The price gap is now closed.
LIT CXO SAV LAXXF LIACF CYDVF PFFOF WML POR ABEPF SQM MLNLF KOD AVLNF KDR SYA STLHF WMLLF LNRDY ADV ABE NGZ LMMFF GXY LRS PLU MNIKF HNR AMLM AVL ALB DMNXF MALRY LACDF MIN LKE DDXFF MGXMF PLUUF DJIFF PSC EMH CRECF LAC PLS NNO LTMCF DJI PDDTF NTTHF NNOMF AVLIF CYP MALRF ORE AVZ AJM

 
Tesla Signs Lithium Supply Deal With China’s Biggest Producer

2018-09-21 oilprice
Tsvetana is a writer for the U.S.-based Divergente LLC consulting firm with over a decade of experience writing for news outlets such as iNVEZZ and…
KDR

 
Johnston to decide Kidman tenement fate

2018-09-17 businessnews.com.au
Shares in lithium hopeful Kidman Resources dropped 15 per cent to be $1.08 each after the company acknowledged a Warden’s Court ruling last week which recommended Kidman not be exempt from past minimum expenditure obligations on tenements at its Mt Holland project.
KDR

 
WA lithium miner heralds commitment to Australia after legal hurdle

2018-09-17 theage.com.au
Kidman Resources has defended its commitment to Australian lithium as the company tries to convince the WA Mines and Petroleum Minister to exempt it from spending obligations on tenements associated with its planned Mt Holland lithium project.
KDR

 
WA lithium miner heralds commitment to Australia after legal hurdle

2018-09-17 smh.com.au
Kidman Resources has defended its commitment to Australian lithium as the company tries to convince the WA Mines and Petroleum Minister to exempt it from spending obligations on tenements associated with its planned Mt Holland lithium project.
KDR

 
Aussie mining dispute could create headaches for Tesla

2018-09-15 theage.com.au
A Western Australian mining lithium project that has an agreement to supply Elon Musk's Tesla faces a legal hurdle that may delay plans to start production, potentially spurring shortages of the mineral used in batteries for electric cars.
KDR

 
Aussie mining dispute could create headaches for Tesla

2018-09-15 smh.com.au
A Western Australian mining lithium project that has an agreement to supply Elon Musk's Tesla faces a legal hurdle that may delay plans to start production, potentially spurring shortages of the mineral used in batteries for electric cars.
KDR

 
Global lithium demand set to double in five years to meet EV demand

2018-09-12 australianmining.com.au
A new report from GlobalData predicts that electric vehicle (EV) demand will double global lithium production from 26,700 tonnes (t) in 20180 to 58,300t in 2022.
PLS PILBF KDR ALTAF AJM

4
Lithium Junior Miner News For The Month Of August 2018

2018-08-27 seekingalpha - 1
Lithium market news - China’s lithium price decline is not the full picture to an industry surging.
LIT CXO SAV LAXXF LIACF AGY PFFOF WML POR ABEPF SQM MLNLF AVLNF AIS.H KDR SYA STLHF WMLLF LNRDY ADV ABE NGZ LMMFF GXY LRS PLU MNIKF HNR AMLM AVL ALB DMNXF MALRY MIN ARYMF LKE DDXFF MGXMF PLUUF DJIFF PSC EMH CRECF ERPNF PLS GSC NNO LTMCF DJI PDDTF NTTHF NNOMF AVLIF MALRF ORE AVZ AJM

 
Zenith Minerals confirms lithium pegmatites at Split Rocks Project in WA

2018-08-14 proactiveinvestors.com.au
Zenith Minerals Ltd (ASX:ZNC) has hit thick pegmatite bodies with potential lithium mineralisation in reverse circulation (RC) drilling at its Split Rocks Project along the Forrestania Greenstone Belt in Western Australia.
KDR ZNC

1
Another mining evolution emerges in Western Australia’s Goldfields

2018-08-06 australianmining.com.au
As the gold industry hits its latest milestone in Kalgoorlie-Boulder, new opportunities have also arrived in the famous mining region. Ben Creagh writes.
ELKMF KDR GFI.WI MALRY DCN AU IGO IIDDY MIN AULGF GOR AGG GFI MALRF GFIOF

1
Lithium Miners News For The Month Of July 2018

2018-07-25 seekingalpha
Lithium market - Goldman: Concerns about a wave of supply of the electric car battery material from new mines are unfounded. The selloff in companies tied to lithium is overdone.
LIT BCN PILBF LTHHF CXO SAV LAXXF LIACF AGY NMT KSN PLLLY RDRUY AZZVF WML MLNLF AIS.H KDR DFS SYA STLHF WMLLF LNRDY NGZ LMMFF GXY TAW LRS MNIKF ILHMF AMLM DMNXF MALRY BGS LACDF EEYMF MIN NMKEF ARYMF ILC GALXF MGXMF LSSCF ALTAF DJIFF NMX EMH PSC CRECF OROCF ERPNF LAC PLS FTI.WI FMC BCN TWNAF DJI RRSSF PDDTF NTTHF AVLIF MALRF ORE AVZ AJM BCRMF

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...